Podcasts about regulatory

In this insightful conversation, Rosa Leal shares her inspiring journey from designing NASCAR alternators to leading commercial product strategy and customer experience at Rheem. With over 20 patents and a passion for innovation, Rosa reflects on how empathy, listening, and collaboration have shaped her leadership approach across engineering and product development. She dives into the complexity of designing for layered customer ecosystems, the importance of staying ahead of regulatory shifts, and how her experience as an immigrant and non-native English speaker sharpened her ability to truly hear customer needs. Rosa also unpacks the role of product management in aligning internal teams, managing risk through stage-gate processes, and fostering a culture where ideas and challenges are welcomed. This episode is a blueprint for leaders who want to drive innovation without sacrificing humility or humanity. Additional Resources: Strategic Leader | Engineer | Patent Holder | Selected as one of the 2023 Top Women in HVAC and Engineered Systems's 2023 20 to Watch: Women in HVAC Attend Unleashing Leaders University! Learn more about Unleashing Leaders Follow Unleashing Leaders on LinkedIn Connect with Lee on LinkedIn Follow Unleashing Leaders on Facebook Follow Unleashing Leaders on Instagram Key Takeaways: Innovation starts with truly listening to customers. Product strategy succeeds when cross-functional teams align early. Empathy, kindness, and clarity drive stronger leadership. Regulatory shifts are opportunities, not obstacles. Building trust enables open, risk-aware innovation.  

In this candid, practice-focused conversation, Joe is joined by Norwegian psychologist and researcher Ivar Goksøyr to explore how therapists' own healing journeys can measurably improve client outcomes—and why MDMA-assisted experiences, used thoughtfully, may be a uniquely powerful catalyst for professional development. Ivar shares lessons from Norway's psychedelic research team (PTSD and the world's first MDMA-for-depression trial), his clinic Psykologvirke in Oslo, and his online course, “The Wounded Healer,” which uses authentic footage from his FDA-approved MAPS volunteer MDMA sessions to illuminate real clinical processes, countertransference, and the “inner healing intelligence” as a working metaphor rather than dogma. The discussion ranges from implementation realities (laws, ethics, and conservative regulatory cultures) to the pragmatic: how an MDMA experience helped Ivar resolve chronic anxiety reactions in the therapy chair, reduced burn-out, increased receptivity, and improved attunement—changes he believes many clinicians can cultivate when personal growth is prioritized alongside methods training. He outlines a developing collaboration with the University of Oslo on Empathogen-Assisted Therapies Development—not to “dose for certification,” but to support therapists' self-awareness and resilience in legally sanctioned research contexts. They also compare compounds: why MDMA may be easier to integrate into mainstream psychiatry than classic tryptamines (fewer projective processes, more biographical focus, smoother affect regulation), while acknowledging the immense promise—and higher demands—of psilocybin and other psychedelics. Throughout, they emphasize humility, guardrails, and the need to keep learning as the field scales (with frank reflections on ketamine's mixed rollout and avoiding idealization/devaluation cycles). Highlights Why therapist factors often outweigh modality—and how personal work translates into better outcomes. Using real session video (with Ivar as participant) to normalize vulnerability, illuminate process, and train pattern recognition. Regulatory and ethical nuances of self-experience in training; building consensus before policy change. Inner healing intelligence as a clinical metaphor aligned with Rogers, Rank, and psychodynamic concepts (unconscious therapeutic alliance). MDMA vs. classic psychedelics for implementation; sequencing with ketamine in public systems. Global classroom: 270+ clinicians from every continent; course structure centered on reflection, discussion, and live analysis.

In this episode of the Pipeliners Podcast, Jim Curry of Babst Calland returns for an in-depth discussion on current and upcoming PHMSA rulemakings.  The conversation covers the agency's evolving focus on risk-based, technology-driven regulation — including the growing role of AI and advanced analytical tools — and what these changes mean for operators. Curry also provides insights into regulatory reform, repair criteria modernization, and how industry can engage proactively to shape durable, data-driven rules that improve safety and efficiency.   Visit PipelinePodcastNetwork.com for a full episode transcript, as well as detailed show notes with relevant links and insider term definitions.

In this episode, Duane Mancini sits downs with Leo Eisner, a seasoned expert in medical device safety and compliance, as he shares his extensive experience and knowledge on the IEC 60601 standards. With a career spanning over 40 years, Leo talks about his beginnings at NASA, his role in the development of medical safety standards, and the intricacies of compliance testing. Discover the complexities of the IEC 60601 updates, the importance of staying informed, and practical advice for medical device manufacturers.Leo Eisner LinkedInEisner Safety Consultants WebsiteImpacts on IEC 60601-1 WebinarDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedIn

In this episode, Uzair talks to Zeeshan Khattak, Commissioner at the Securities & Exchange Commission of Pakistan (SECP) about the deepening of financial markets in Pakistan and the ways in which the SECP is trying to expand access to finance at the individual and corporate level. Mr. Zeeshan Rehman Khattak joined the SECP as Commissioner in November 2024. He has over two decades of local and international experience in Real Estate Investment & Management, Regulatory Affairs, Wealth Management, and Development of Export-led Technology Infrastructure. Mr. Khattak brings rich experience in capital markets, regulatory oversight and assets' management. Mr. Khattak's most recent association was with Pakistan Software Export Board (PSEB) as Chief Commercial Officer and additionally as Chief Executive Officer designate. Chapters: 0:00 Introduction 2:20 SECP's priorities 11:25 Savings via digital gold 14:20 Regulatory sandboxes 25:05 Focus on startups 27:30 Climate finance

Mark Hamilton sits down to discuss some of the latest news stories in F1. Mark also looks towards the Singapore Grand Prix. Looking for unique and authentic F1 merchandise? Check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.racingexclusives.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Check out The RaceWknd magazine ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Title music created by J.T. the Human: https://www.jtthehuman.com/ Hit that subscribe button and tune in for the full, unfiltered breakdown! You don't wanna miss this!

On this week's episode of Passive Income Playbook, Pascal Wagner interviews Peter Sack. They dig into why Chicago Atlantic targets underserved private credit niches, especially state-by-state cannabis lending where limited competition can mean first-lien structures at lower leverage with mid-teens to ~20% returns, plus classic lender protections. Peter explains how regulatory moats, disciplined underwriting, and downside focus beat “sexy” equity stories, and how potential legalization would likely trigger refinancings, prepayment fees, and warrant upside rather than harm. They also compare private funds to public options through Chicago Atlantic's BDC and mortgage REIT tickers, LIEN and REFI, and outline what LPs should evaluate in credit managers from lien position to non-accruals and third-party administration. Peter SackCurrent role: Managing Partner, Chicago AtlanticBased in: Miami, FloridaSay hi to them at: https://www.chicagoatlantic.com/ | LinkedIn | investors@chicagoatlantic.com This is a limited time offer, so head over to aspenfunds.us/bestever to download the investor deck—or grab their quick-start guide if you're brand new to oil and gas investing. Get 50% Off Monarch Money, the all-in-one financial tool at www.monarchmoney.com with code BESTEVER Join the Best Ever Community  The Best Ever Community is live and growing - and we want serious commercial real estate investors like you inside. It's free to join, but you must apply and meet the criteria.  Connect with top operators, LPs, GPs, and more, get real insights, and be part of a curated network built to help you grow. Apply now at ⁠www.bestevercommunity.com⁠ Podcast production done by ⁠Outlier Audio⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Danielle Kidney is the founder of The Creative Pack, a Los Angeles-based agency specializing in packaging design for CPG and DTC brands. With over two decades of experience in the industry—including work with Tesco and a diverse portfolio of well-known consumer brands—Danielle brings a wealth of expertise in every aspect of packaging, from strategy and brand storytelling to materials and production.In this episode of DTC Pod, Danielle breaks down the behind-the-scenes process of creating packaging that not only looks great but also delivers on function, compliance, and scalability. She covers everything from the earliest stages of design and competitor audits, to the nuances of materials, regulatory requirements, and print production. Danielle shares practical advice on how brands can avoid costly mistakes, streamline their supply chain, and create packaging that stands out both online and on the shelf.Episode brought to you by StordInteract with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. The importance of packaging in brand perception and sales2. Process: From initial idea to production-ready design3. Building a design brief and establishing project scope4. Competitive reviews and designing for hierarchy and function5. Balancing creative innovation with must-have regulatory details6. Collaborating with clients, manufacturers, and printers7. Prototyping, mockups, and unboxing experience8. Print technology, material choices, and cost management9. Regulatory review, legal claims, and compliance essentials10. Lead times, timeline planning, and pitfalls of rushing production11. Early-stage packaging vs. scaling up for retail and DTC12. Lessons learned: common mistakes and strategic tips13. Pricing, form factor, and packaging design as sales leversTimestamps00:00 Introducing Danielle Kidney & The Creative Pack05:42 The Creative Pack's client process: from idea to brief10:50 Balancing branding vs. functionality for sales and conversion18:03 Manufacturing realities: materials, dielines, and cost constraints24:39 Colors, mockups, and bringing digital designs to life26:22 Real-world costs of packaging mistakes and risk mitigation29:27 Regulatory musts: nutrition facts, barcodes, legal pitfalls35:10 Realistic timelines for packaging launches and scale40:33 Strategies for startups vs. brands scaling up43:23 Lessons learned and tips for optimizing packaging decisions50:20 Where to connect with Danielle and The Creative PackShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more.  Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• ​​​​#243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTokDanielle Kidney - Founder of The Creative PackBlaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic

This webinar explores key developments in environmental regulatory compliance requirements affecting businesses operating across international jurisdictions, with a focus on how evolving rules are reshaping sustainability and ESG obligations for businesses.

If you have built your BigLaw career around a thriving regulatory or enforcement practice, you know how difficult it can be for you and your practice when that work suddenly isn't there. One month you are buried in nvestigations motivated by government inquiries or merger reviews, and the next your phone goes quiet because enforcement priorities shifted, agency budgets got cut, or a new administration has redirected resources. It is unsettling, especially when your brand, reputation and and client base are tied to that flow of work. In this episode, I walk through the reality of what it can feel like and what to do when your once-busy enforcement and regulatory practice slows. I share how to distinguish between cyclical downturns and structural changes that reshape a practice like this long term, and share some specific examples across areas such as FCPA, antitrust, and privacy to illustrate how BigLaw attorneys can pivot effectively. I also outline practical steps to stay visible with clients as well as inside your firm so that even when the billable work is not there, your value and future opportunities are. At a Glance: 00:00 Introduction need to navigate BigLaw downturns in regulatory and enforcement work 01:20 When busy practices suddenly dry up: regulatory shifts and enforcement changes 02:14 How external forces such as politics, budgets, and agency leadership reshape your practice overnight 03:03 Early warning signs that your work is slowing down in these areas 03:37 The emotional impact: anxiety, uncertainty, and fear of career derailment 04:08 Diagnosing cyclical vs. structural downturns with concrete indicators 05:16 Why this distinction matters for your long-term career strategy 05:39 Examples of temporary pivots that kept practices alive (FCPA, antitrust, GDPR, privacy) 07:04 How lawyers can broaden their practices to adapt to structural changes 08:08 The importance of proactive client communication, including with “good news” updates 09:37 What to do when billable hours stall: seeking work across departments and staying visible 10:41 Positioning yourself as a thought leader through articles, CLEs, and conferences 11:29 Documenting outreach, cross-practice contributions, and client loyalty for firm leadership 12:21 Demonstrating cross-practice value: aligning with busier groups inside your firm 13:30 How client loyalty and referrals strengthen your standing even in slow periods 13:58 Reframing your practice to be less narrowly defined by one enforcement area 14:27 How one partner survived cuts by documenting value and broadening expertise 15:16 Long-game mindset: showing your firm that you are indispensable beyond billable hours Rate, Review, & Follow on Apple Podcasts & Spotify Do you enjoy listening to Big Law Life?  Please consider rating and reviewing the show! This helps support and reach more people like you who want to grow a career in Big Law.  For Apple Podcasts, click here, scroll to the bottom, tap to rate with five stars, and select “Write a Review.” Then be sure to let me know what you loved most about the episode! Also, if you haven't done so already, follow the podcast here!  For Spotify, tap here on your mobile phone, follow the podcast, listen to the show, then find the rating icon below the description, and tap to rate with five stars. Interested in doing 1-2-1 coaching with Laura Terrell? Or learning more about her work coaching and consulting? Here are ways to reach out to her: www.lauraterrell.com  laura@lauraterrell.com   LinkedIn: https://www.linkedin.com/in/lauralterrell/  Instagram: https://www.instagram.com/lauraterrellcoaching/  Show notes: https://www.lauraterrell.com/podcast

Medboard Europe TToo much Incomplete Tech File - Let's explain to you how to do it: https://www.team-nb.org/wp-content/uploads/2025/09/Team-NB-PositionPaper-BPG-IVDR-V2-20250903.pdf 2025/1920 on Master UDI-DI - Not only lenses but also Spectacle frames and Ready-to-wear: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202501920 Borderline manual Update -  New products included: https://health.ec.europa.eu/document/download/71a87df8-5ca1-4555-b453-b65bdf8de909_en?filename=md_borderline_manual_en.pdf red blood cell additive solutions containing adenine dual action cream with menthol and capsaicin Lactose tablets for vaginal use microabrasion dental stain removers medical examination table covers Mobile sterile air system   EU asks your feedback on EU MDR and IVDR - Enjoy reading some 100 feedbacks: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/14808-Medical-devices-and-in-vitro-diagnostics-targeted-revision-of-EU-rules_en Switzerland Swissdamed Technical Documentation - XML upload: https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-informationen/swissdamed-technical-documents.html Business Rules Swissdamed: https://www.swissmedic.ch/dam/swissmedic/en/dokumente/medizinprodukte/mep_urr/bw630_40_002e_pu_swissdamed_business_rules.pdf.download.pdf/BW630_40_002e_PU_swissdamed_Business_Rules.pdf   UK UK PMS guidance for Report - Template available: https://www.gov.uk/government/publications/medical-devices-post-market-surveillance-requirements/requirements-of-the-manufacturers-pms-system PMSR Template: https://www.gov.uk/government/publications/medical-devices-standardised-format-for-the-post-market-surveillance-report   Magazine Issue 1: Sept/Oct 2025 - Next one will come November 2025: https://easymedicaldevice.com/emd-mag/ Events Medtech Conf events - Be listed on the MAP: https://medtechconf.com/events-map-2/ EasyIFU Free trial for eIFU with EASYIFU - Compliant EU 2025/1234: https://easyifu.com ROW US FDA Computer System Assurance - SOP offered on the show notes: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/computer-software-assurance-production-and-quality-system-software-0 Malaysia affiliate member of MDSAP - What does it change?:  https://portal.mda.gov.my/index.php/announcement/1636-malaysia-is-now-mdsap-medical-device-single-audit-program-mdsap-member Australia Essential Principles Checklist Update -: Update the templates V1.2: https://www.tga.gov.au/resources/resource/checklists/essential-principles-checklist Egypt guidance to import your devices - Medical Devices, Accessories, IVD: All type of devices: https://edaegypt.gov.eg/media/lafopofx/1-regulatory-guideline-of-issuance-of-import-approvals-of-all-types-of-medical-devices_gd.pdf Medical Equipment and Accessories: https://edaegypt.gov.eg/media/fltnd1qc/4-regulatory-guideline-of-issuing-import-approvals-for-medical-equipment-and-their-accessories_gd.pdf IVD: https://edaegypt.gov.eg/media/e2rf4qg5/2-regulatory-guideline-of-the-procedures-and-rules-of-obtaining-import-approvals-for-iaboratory-and-diagnostic-equipment-gd.pdf   Podcast Episode 353: Cybersecurity in Medical Devices: What QA/RA must do Today: https://podcast.easymedicaldevice.com/353-2/ Episode 354: From Surgeon to CEO: Building Neurogyn AG: https://podcast.easymedicaldevice.com/354-2/ Episode 355: Postmarket Surveillance for SaMD and AI: https://podcast.easymedicaldevice.com/355-2/ Easy Medical Device Service Support for Consulting (QA RA projects) Support for Authorized Representative and Market Access Integration to an eQMS Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice

In this episode, Jesse Gordon-Blake, PhD, delves into the intricacies of medicinal chemistry, particularly focusing on drug discovery for ALS (amyotrophic lateral sclerosis). Jesse explains the process of discovering molecules that modulate biological pathways, the difference between structure-based and phenotype-based drug design, and the role computational methods play in drug development. The conversation also explores the challenges of crossing the blood-brain barrier, the importance of validating target response, and the complexities of progressing from a theoretical compound to preclinical studies. Additionally, Jesse touches on the significance of target product profiles, CNS drug design characteristics, and the iterative nature of medicinal chemistry. He concludes by discussing his current projects at Cortex, including fundraising strategies and timelines for drug development.00:00 Introduction to Medicinal Chemistry00:37 Drug Discovery Approaches02:01 Computational Methods in Medicinal Chemistry03:21 Challenges in ALS Drug Discovery04:23 Blood-Brain Barrier and Drug Design05:29 Key Properties for CNS Drug Design08:58 Day-to-Day in Drug Discovery09:45 Early Stage Drug Development12:28 Validating Drug Targets16:15 From Theory to Animal Testing22:46 Funding and Timeline Considerations25:45 Regulatory and Manufacturing Considerations28:32 Conclusion and Contact InformationDr. Jesse Gordon-Blake is an independent biotechnology and drug discovery consultant with expertise in medicinal chemistry and neurotherapeutics. He has led efforts in small molecule and peptide therapeutic development, AI-enabled drug discovery, and biotech startup formation, and currently serves as the CSO of Cortexa Therapeutics. He earned his PhD in Medicinal Chemistry from the University of Illinois at Chicago, focusing on developing innovative small-molecule enzyme modulators for Alzheimer's disease.https://www.linkedin.com/in/jesse-gordon-blake-phd-52a26274/https://www.cortexatherapeutics.com/Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

The award-winning Compliance into the Weeds is the only weekly podcast that takes a deep dive into a compliance-related topic, literally going into the weeds to explore a subject more fully. Looking for some hard-hitting insights on compliance? Look no further than Compliance into the Weeds! In this episode of Compliance into the Weeds, Tom Fox and Matt Kelly discuss the bot attack on Cracker Barrel during its abortive name change imbroglio. They explore the notion that social media risk is not a new concept, but rather an amplifier of existing risks for companies. It discusses the heightened potential for misinformation about a company's values and how social media platforms have magnified this risk. Regulatory measures and accountability issues are addressed, with a nod to the role of prominent figures like Elon Musk. The episode underscores the inevitable, albeit unfair, reality of managing these amplified risks in today's digital landscape. Key highlights: Introduction to Social Media Risks Amplification of Existing Risks Challenges in Managing Misconceptions The Unavoidable Reality of Social Media Accountability Resources: Matt on Radical Compliance Tom Instagram Facebook YouTube Twitter LinkedIn A multi-award-winning podcast, Compliance into the Weeds was most recently honored as one of the Top 25 Regulatory Compliance Podcasts, a Top 10 Business Law Podcast, and a Top 12 Risk Management Podcast. Compliance into the Weeds has been honored with a Davey, Communicator, and W3 Award for podcast excellence. Learn more about your ad choices. Visit megaphone.fm/adchoices

Regulatory whiplash in California as the state effectively held a funeral for the two largest components of the Advanced Clean Fleet Rules, including mandates for high-priority fleets and drayage trucks. Despite the official withdrawal of these mandates by CARB, zero-emission vehicle sales are surprisingly growing in the state, suggesting market momentum is now driven by factors beyond regulatory pressure. The ongoing pricing standoff in the parcel sector, where UPS and FedEx are imposing significant peak season surcharges despite projections for muted demand growth, has heated up. Analysts warn that demanding these high fees in a soft market is short-sighted, leading to a major diversion of volume to alternative carriers like Amazon, Walmart, and independent services like OnTrac. Our brief concludes with the tectonic plates shifting in corporate freight strategy, starting with the massive $85 billion UP-NS merger that is already forcing competitors like CSX to seek its own merger partner after a CEO change. Meanwhile, ArcBest unveiled an ambitious plan to double its adjusted earnings per share by 2028 by targeting a highly optimized, asset-based operating ratio of 87% to 90% through technology and cost controls. Finally, we address the industry's perennial challenge of safety, noting that Wyoming currently tops the list for deadly truck crashes by death rate while Texas leads the nation in total fatalities by volume. These sobering statistics are fueling calls from victim advocates for mandatory safety technology, specifically demanding that all new commercial trucks be equipped with Automatic Emergency Braking. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode of the Pipeliners Podcast features a conversation with Osten Olorunsola of Aradel Holdings about the opportunities and challenges of building measurement capability at the national level in Nigeria. The discussion explores the critical role of measurement in oil and gas operations, the regulatory landscape, and the impact of shifting from multinational operators to indigenous companies. Listeners gain insight into how Nigeria is working to standardize practices, close capability gaps, and strengthen its long-term energy infrastructure.   Visit PipelinePodcastNetwork.com for a full episode transcript, as well as detailed show notes with relevant links and insider term definitions.

In this episode of Medsider Radio, we sat down with Josh Vose, CEO of Tulavi Therapeutics.Tulavi is advancing hydrogel-based implants like the allay Hydrogel Cap, which is designed to optimize nerve injury recovery and reduce the risk of neuroma formation.Josh is a physician, engineer, and entrepreneur with more than 20 years of experience in medical devices. He has held leadership roles at Medtronic following its acquisition of PEAK Surgical and drove growth at startups including SIA Health, which he led through commercialization and acquisition by Integra LifeSciences.In this interview, Josh shares why defining the clinical problem with absolute clarity is the foundation of medtech success, and how leaning into the harder regulatory path can create lasting moats.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Josh Vose.

Adam Stettner believes the cannabis industry is primed for growth acceleration but faces critical roadblocks from D.C. Optimism was sparked after President Trump made a social media post that endorsed CBD use for seniors. Adam talks about the state and federal challenges for cannabis as the steps companies need to take ahead of potential legalization.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

PM Dickon Mitchell has announced that Grenada will host the headquarters of the new Caribbean CBI regulatory authority.View the full article here.Subscribe to the IMI Daily newsletter here. 

I'll discuss the difference between a regulatory body and professional assocation. Episode Show Notes: kayladas.com/episode136 Free Boosting Business Community: facebook.com/groups/exclusiveprivatepracticecommunity Snap SEO: snapseo.ca Credits & Disclaimers Music by ItsWatR from Pixabay The Designer Practice Podcast and Evaspare Inc. has an affiliate and/or sponsorship relationship for advertisements in our podcast episodes. We receive commission or monetary compensation, at no extra cost to you, when you use our promotional codes and/or check out advertisement links.

Regulatory whiplash in California as the state effectively held a funeral for the two largest components of the Advanced Clean Fleet Rules, including mandates for high-priority fleets and drayage trucks. Despite the official withdrawal of these mandates by CARB, zero-emission vehicle sales are surprisingly growing in the state, suggesting market momentum is now driven by factors beyond regulatory pressure. The ongoing pricing standoff in the parcel sector, where UPS and FedEx are imposing significant peak season surcharges despite projections for muted demand growth, has heated up. Analysts warn that demanding these high fees in a soft market is short-sighted, leading to a major diversion of volume to alternative carriers like Amazon, Walmart, and independent services like OnTrac. Our brief concludes with the tectonic plates shifting in corporate freight strategy, starting with the massive $85 billion UP-NS merger that is already forcing competitors like CSX to seek its own merger partner after a CEO change. Meanwhile, ArcBest unveiled an ambitious plan to double its adjusted earnings per share by 2028 by targeting a highly optimized, asset-based operating ratio of 87% to 90% through technology and cost controls. Finally, we address the industry's perennial challenge of safety, noting that Wyoming currently tops the list for deadly truck crashes by death rate while Texas leads the nation in total fatalities by volume. These sobering statistics are fueling calls from victim advocates for mandatory safety technology, specifically demanding that all new commercial trucks be equipped with Automatic Emergency Braking. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Yet Another Value Podcast, host Andrew Walker welcomes back Steve Gorelik from Firebird Management for a deep dive into Molina Healthcare (ticker: MOH). Together, they explore the sharp drop in Molina's stock despite its long-standing compounder reputation. Steve outlines how Molina operates as a low-cost Medicaid-focused managed care organization, making it uniquely resilient amid rising medical costs and regulatory challenges. They discuss Molina's competitive advantages, risks tied to healthcare policy, redetermination effects, and its strategic M&A playbook. Tune in to understand why Steve believes Molina remains undervalued and poised to outperform its peers—even as the broader Medicaid sector stumbles.___________________________________________________________[00:00:00] Intro and sponsor mention[00:02:25] What is Molina Healthcare?[00:05:31] Medicaid model and revenue growth[00:06:25] Molina stock chart and July crash[00:07:13] Industry-wide margin compression[00:11:28] Why Steve sees alpha in Molina[00:13:29] ROE vs. cost structure explained[00:15:04] Admin efficiency as competitive edge[00:17:04] Molina's playbook and cost culture[00:20:16] Medicaid redetermination impact[00:24:07] Market share gains amid member losses[00:26:26] What's driving cost inflation now[00:28:44] Will premiums rise to match costs?[00:30:26] Regulatory risks in Medicaid[00:32:19] Medicaid vs. private cost efficiency[00:33:54] Denials, approvals, and outcomes[00:37:50] Molina's denials as cost control[00:40:42] Tender process and doctor networks[00:41:43] What keeps Steve up at night[00:44:41] Acquisitions: model and pipeline[00:47:18] M&A parallels to John Malone[00:48:19] CEO incentives and share ownership[00:50:48] Share buybacks and capital returns[00:51:19] Could Molina be acquired?[00:52:57] Long-term compounding vs. exit[00:53:28] Scooby-Doo investing explained[00:54:23] Wrapping up the conversationLinks:Yet Another Value Blog - https://www.yetanothervalueblog.com See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer

Joel Hawthorne shares his outlook on the crypto market's surprising comeback, fueled by positive regulatory conversations and increased institutional interest. He believes the recent rally in Coinbase (COIN) is tied to the broader market's bullish momentum.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Episode overviewIn this special episode, hosts and Co-Chief Investment Strategists Kevin Headland and Macan Nia welcome Nathan William Thooft, Chief Investment Officer for Multi Assets and Equities at Manulife Investments. Nate shares his global perspective on markets, asset allocation, and the evolving investment landscape, with insights tailored for Canadian investors.---Key topics & insights1. U.S. economic outlook: resilience amid uncertainty· No imminent recession expected—Nate explains that while recent U.S. labor market data has softened, it's not likely a signal for an imminent recession. The U.S. economy's balance between manufacturing and services helps offset sector-specific weaknesses.· Policy uncertainty—Earlier legislative and tariff changes have caused “paralysis” in company decision-making, but clarity is expected to improve economic data in coming months.· New paradigm—The severity of future U.S. recessions may be more muted due to the economy's diversification.2. Inflation & tariffs: what's really happening?· Tariff impact delayed—Studies show tariffs typically take up to a year to affect inflation. Many imports are exempt, and companies are absorbing costs, leading to lower-than-expected inflationary effects.· Substitution effect—Companies are shifting imports to countries with lower tariffs, further dampening inflation pressures.  3. Regional equity markets: Europe & Asia· Europe's outperformance—European equities have surprised with strong returns in 2025. Nate attributes this to a sentiment shift away from the U.S. amid geopolitical uncertainty, but sees it as opportunistic rather than a long-term trend.· Active vs. passive management—Active management is especially valuable in regions like Europe and Asia, where opportunities are less covered.· China's mixed signals—Despite strong equity performance and policy support, China's fundamentals (consumer spending, industrial production) remain weak. Nate is cautiously optimistic, citing potential in technology and AI, and improving sentiment.4. Asset allocation: equities vs. fixed income· Modest equity overweight—Manulife portfolios remain overweight equities, reflecting solid fundamentals despite stretched valuations.· Fixed income caution—Less conviction in long-duration fixed income due to changing yield curve dynamics and rising term premiums.· Diversification beyond 60/40—Nate advocates for broader diversification, including alternative assets, to manage risk.5. Private Assets & Alternatives· Democratization of privates—The trend toward making private assets (infrastructure, private credit, real estate) accessible to retail investors is accelerating, as seen in recent industry partnerships.· Role in portfolios—Private assets offer diversification and potential downside protection, especially when traditional fixed income may be less effective.6. Artificial Intelligence (AI) in asset management· Efficiency & speed—AI is transforming research, data analysis, and commentary writing, but won't replace portfolio managers who bring creativity and intellectual capital.· Research revolution—AI enables analysis of vast data sets, improving productivity and decision-making.  7. Cryptocurrency: a legitimate asset class?· Growing acceptance—Nate views crypto as a legitimate asset class, though volatility and regulatory uncertainty mean exposures should remain modest and client-specific.· Regulatory trends—As demand grows, policy is likely to become more accommodating.8. Career advice for aspiring portfolio managers· Decisiveness—Don't wait for perfect information—make decisions with 60–80% of the data to avoid missing opportunities.· Passion & objectivity—Be passionate about investing, but unemotional in decision-making. The ability to cut losses and remain objective is crucial for success.---Actionable takeaways for Canadian investors· Stay diversified—Consider global opportunities and alternatives beyond traditional stocks and bonds.· Monitor policy impacts—Watch for delayed effects from tariffs and monetary policy.· Embrace active management—Especially in regions with less coverage and more inefficiencies.· Explore private assets—As access expands, these can enhance portfolio resilience.· Leverage technology—AI will increasingly support research and efficiency, but human insight remains essential.---Links & Resources · Listen to the episode: Investments Unplugged Podcast · Learn more about Manulife Investments: Manulife IM Canada---Share & SubscribeIf you enjoyed this episode, please share it with your network and subscribe for future insights on markets, investing, and portfolio strategy.---For informational purposes only. This episode does not constitute investment advice. Please consult a qualified advisor before making investment decisions.---Show notes prepared by Investments Unplugged Podcast Team, September 2025.

North America’s railways are at a crossroads. After decades defined by consolidation and cost-cutting, the sector is pivoting toward growth, but trade volatility, regulatory uncertainty, and merger politics may shape how far it can go. In this conversation with RealAgriculture's founder Shaun Haney, Anthony Hatch, of ABH Consulting, lays out the forces at play in... Read More

A recent case filed by the U.S. Department of Justice (DOJ) reveals how an insider was able to detect fraud in a large managed care organization (MCO).Although the topic of medical loss ratio (MLR) might be arcane to some, when the subject involves millions of dollars of potential fraud, it quickly becomes a large blip on the government's fraud detection radar.More on this topic will be reported during the next live edition of Monitor Mondays. That's when whistleblower attorney Max Voldman returns to the long-running Internet broadcast to report on how a payer, Inland Empire Health Plan, miscalculated its MLR in a scheme to rebate less money to the government than to which it was legally obligated.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Cate Brantley, senior legislative affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

In this crossover episode of The Consumer Finance Podcast and Regulatory Oversight, Chris Willis is joined by Joseph DeFazio, Bill Foley, and Michael Yaghi to discuss the implications of New York's FAIR Act, a significant amendment to the state's UDAAP statute. The FAIR Act aims to broaden consumer protection by lowering the threshold for legal action against unfair and abusive business practices. With expanded enforcement powers for the state, this legislation could dramatically increase litigation risks for financial services companies operating in New York if the governor signs the bill. Tune in to understand how this legislative shift might affect the industry and what steps businesses can take to prepare. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Managed service providers (MSPs) are experiencing significant growth driven by interest in artificial intelligence (AI), with 92% reporting an uptick in business. However, a concerning trend has emerged: only about half of these providers feel equipped to assist small and mid-sized businesses in adopting AI tools, a sharp decline from 90% the previous year. This growing readiness gap highlights the challenges MSPs face in meeting customer expectations as AI adoption accelerates. Experts emphasize the need for integrated security solutions to help navigate the complexities of AI.OpenAI's recent benchmarks reveal that a staggering 95% of enterprise AI projects fail, underscoring the difficulties companies encounter in justifying their AI investments. Despite advancements in AI models, their effectiveness remains inconsistent, particularly in handling complex, ongoing projects. The evaluation system introduced by OpenAI aims to bridge the gap between theoretical capabilities and real-world demands, indicating that while AI can perform tasks faster and cheaper than humans, it still struggles with contextual understanding and interaction.In the realm of digital content, Cloudflare has launched a feature allowing website owners to block Google's AI overview search product, addressing concerns from publishers about traffic losses due to AI-generated content. This move comes amid legal challenges faced by Google from publishers who argue that their content is being used without proper attribution. While Cloudflare's feature offers a potential solution, its effectiveness hinges on Google's compliance, raising questions about the future of content ownership in the age of AI.Regulatory pressures are also reshaping the landscape for major tech companies. Microsoft has been compelled to offer free extended security updates for Windows 10 in select European markets, responding to consumer advocacy for better support. Meanwhile, Apple has delayed the release of several features in Europe due to compliance challenges with the EU's Digital Markets Act. These developments highlight the increasing influence of regulation on technology services, prompting MSPs to prepare for client inquiries regarding disparities in service offerings across regions.Four things to know today00:00 92% of MSPs Report AI-Driven Growth, But Only Half Feel Ready to Support SMB Adoption02:50 Fast, Cheap, and Fragile: OpenAI Finds AI Struggles in Real Work While Cloudflare Challenges Google's AI Overviews06:44 EU Pressure Forces Microsoft to Extend Free Windows 10 Updates as Apple Delays Features Under DMA09:39 Innovation vs. Obligation: How Debt, Automation, and AI Metrics Are Rewriting the Managed Services PlaybookThis is the Business of Tech.    Supported by:  https://mailprotector.com/ Webinar:  https://bit.ly/msprmail All our Sponsors: https://businessof.tech/sponsors/ Do you want the show on your podcast app or the written versions of the stories? Subscribe to the Business of Tech: https://www.businessof.tech/subscribe/Looking for a link from the stories? The entire script of the show, with links to articles, are posted in each story on https://www.businessof.tech/ Support the show on Patreon: https://patreon.com/mspradio/ Want to be a guest on Business of Tech: Daily 10-Minute IT Services Insights? Send Dave Sobel a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/businessoftech Want our stuff? Cool Merch? Wear “Why Do We Care?” - Visit https://mspradio.myspreadshop.com Follow us on:LinkedIn: https://www.linkedin.com/company/28908079/YouTube: https://youtube.com/mspradio/Facebook: https://www.facebook.com/mspradionews/Instagram: https://www.instagram.com/mspradio/TikTok: https://www.tiktok.com/@businessoftechBluesky: https://bsky.app/profile/businessof.tech Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This conversation provides a comprehensive overview of the Fifth Amendment, focusing on the due process protections and the takings clause. It explores the historical context of these legal principles, key cases that have shaped their interpretation, and the distinctions between procedural and substantive due process. The discussion delves into regulatory takings, categorical takings, and the Penn Central test, providing insights into how courts analyze these issues. Additionally, it addresses the complexities of temporary takings and exactions, emphasizing the importance of fair compensation and the evolving challenges in environmental law.The Fifth Amendment to the United States Constitution is a cornerstone of American legal principles, safeguarding individual rights against government overreach. Among its provisions, the Takings Clause stands out as a critical element, ensuring that private property cannot be taken for public use without just compensation. This blog post explores the intricacies of the Fifth Amendment and the Takings Clause, shedding light on their significance and impact on property rights.Understanding the Fifth Amendment: The Fifth Amendment is part of the Bill of Rights and provides several protections for individuals, including the right to due process, protection against double jeopardy, and the right against self-incrimination. However, one of its most debated components is the Takings Clause, which addresses the balance between public needs and private property rights.The Takings Clause Explained: The Takings Clause states, "nor shall private property be taken for public use, without just compensation." This clause ensures that when the government needs to acquire private property for public purposes, such as building infrastructure or public facilities, it must provide fair compensation to the property owner. The clause raises important questions about what constitutes "public use" and how "just compensation" is determined.Key Court Cases and Interpretations: Over the years, the U.S. Supreme Court has interpreted the Takings Clause in various landmark cases. One notable case is Kelo v. City of New London (2005), where the Court ruled that economic development can be considered a public use under the Takings Clause. This decision sparked widespread debate and led to legislative changes in several states to protect property owners.The Fifth Amendment and the Takings Clause play a vital role in balancing the interests of the public and private property owners. As legal interpretations evolve, these provisions continue to shape the landscape of property rights in the United States. Understanding their implications is crucial for anyone interested in constitutional law and property rights.Subscribe Now: Stay informed about the latest developments in constitutional law and property rights by subscribing. Don't miss out on insightful analysis and expert commentary.TakeawaysThe Fifth Amendment's property provisions can be complex.Due process includes both procedural and substantive protections.The takings clause requires just compensation for property taken.Historical cases like Chicago, Burlington, and Quincy Railroad are crucial for understanding incorporation.Regulatory takings can occur without physical seizure of property.The Loretto case established a clear rule for permanent physical occupations.The Lucas case defined total deprivation of economic use as a categorical taking.The Penn Central test provides a flexible framework for analyzing regulatory takings.Temporary takings require compensation for the period of denial.Exactions must meet the essential nexus and rough proportionality tests.Fifth Amendment, due process, takings clause, regulatory takings, property rights, compensation, Penn Central, Loretto, Lucas, exactions

Summary The ANO-Talk hosts sit down with Barb “the cleaning lady” and Ed Kanegsberg of BFK Solutions LLC  at the Aluminum Summit in Atlanta Georgia. The conversation explores various themes related to the anodizing industry, including personal anecdotes, resilience in business, the importance of education and training, regulatory challenges, and the significance of employee safety. The speakers emphasize the need for adaptability in the face of changing regulations and the importance of effective communication with regulators. They also discuss the future of anodizing and the dynamics of the supply chain, highlighting the necessity of making learning engaging and fun for employees. Takeaways The importance of resilience and adaptability in business. Education and training should focus on teaching critical thinking. Regulatory challenges are accelerating in the chemical industry. Employee safety is paramount in manufacturing environments. Effective communication with regulators is essential for industry success. The anodizing industry faces unique challenges due to environmental regulations. Making learning engaging can enhance employee retention and understanding. Collaboration between management and technicians leads to better outcomes. Understanding the risks and benefits of chemicals is crucial for safety. The future of anodizing will depend on innovation and adaptability.

In today's episode of iGaming Daily, SBC Media Manager Fernando Noodt is joined by SBC Editor-At-Large Ted Menmuir and SBC Noticias Business Journalist Damian Martinez to unpack Spain's Q2 2025 gambling results, regulatory pressures, and what lies ahead for the market.Tune in to today's episode to find out:How Spain's gambling industry performed in Q2 2025 across all key verticals.What trends in deposits, withdrawals, and marketing spend reveal about player behaviour.Why the government is pushing for AI-driven risk detection systems.How Melilla continues to attract iGaming operators despite national restrictions.Whether 2025/2026 could be remembered as a Renaissance period for Spanish gambling.Host: Fernando NoodtGuests: Ted Menmuir & Damian MartinezProducer: Anaya McDonaldEditor: Anaya McDonaldSecure your spot to join Optimove for an exclusive sweepstakes industry breakfast at G2E on October 7th in Las Vegas! Network with industry leaders and gain key insights while enjoying great conversation. Click HereiGaming Daily is also now on TikTok. Make sure to follow us at iGaming Daily Podcast (@igaming_daily_podcast) | TikTok for bite-size clips from your favourite podcast.Finally, remember to check out Optimove at https://hubs.la/Q02gLC5L0 or go to Optimove.com/sbc to get your first month free when buying the industry's leading customer-loyalty service.

In this conversation, Stephan Livera and Jesse Myers discuss the current state and future of Bitcoin treasury companies, focusing on Smarter Web Company's strategies and performance. They explore the implications of PIPE deals, the importance of a solid track record in delivering Bitcoin yield, and the regulatory environment's impact on investment strategies. The discussion highlights successful examples like Metaplanet and the potential for Bitcoin treasury companies to accumulate a significant portion of Bitcoin in the coming years. They also address the challenges investors face, including understanding mNAV and justifying premiums in Bitcoin investments. Jesse also introduces the P-Bid ratio as a new metric for evaluating these companies, emphasizing the need for a strong retail investor base and the significance of operational businesses in sustaining value. The discussion concludes with reflections on the future of Bitcoin treasury companies and their role in the broader financial landscape.Takeaways:

CEOs are expressing increasing confidence and displaying resilience as they navigate a rapidly shifting geopolitical landscape, according to the latest EY CEO Outlook, with ongoing volatility acting as a catalyst to rethink supply chains, business models, markets and investment priorities. The research, which involved more than 1200 CEOs globally, including 40 senior CEOs here in Ireland, found that while global economic sentiment remains muted, with almost six in ten (57%) of global CEOs expecting geopolitical and economic uncertainty to last well beyond a year, Irish CEOs are notably more confident in their own performance. Six in ten (60%) Irish CEOs expect profitability over the next year, while sentiment in relation to revenue growth is also positive. This confidence stems from a pragmatic but proactive approach to strategy, with leaders increasingly prioritising AI and automation, business model transformation and capability-building through M&A. Particularly notable is the focus from Irish CEOs on regionalisation, with 77% saying that producing and sourcing closer to home has become a long-term strategy. Seven in ten (70%) CEOs have placed regionalisation at the core of their strategy, across operations, supply chains, research and technology. While Irish CEOs remain confident, the survey also provides some cautionary signals, as they are facing a complex mix of financial and operational pressures. Notably, nearly eight in ten (78%) cited optimism around input costs, up from 48% in May. However, the cost of energy was cited as an area of particular concern, with 50% of leaders saying it is directly affecting operational performance. Regulatory complexity is another challenge, with a third citing competing regulations as a barrier to change. Talent constraints are another key area of concern, with confidence in the ability to attract and retain talent declining sharply from 55% in the previous research to just 35%. The drop is most pronounced in high-demand sectors, particularly those requiring digital and technical skills. Globally, most CEOs anticipate that prolonged uncertainty will persist, with 57% of CEOs expecting uncertainty to last beyond a year. Despite this, the survey's CEO Confidence Index - which measures sentiment across strategy, operations, and investment- stands at 83, up seven points since May. Helena O'Dwyer, Partner and Head of Strategy at EY-Parthenon Ireland, said: "Our latest CEO survey finds that, in spite of the ongoing global geopolitical and economic headwinds, CEOs are expressing confidence in their organisation's future and their ability to lead through uncertainty. Following a period earlier this year when many firms adopted a 'wait and see' approach, we are now seeing a shift toward action. Nearly six in ten Irish CEOs say they plan to increase investment in portfolio transformation and strategic M&A over the next 12 months. What stands out from our conversations with clients is a clear focus on divesting assets that are no longer delivering value, simplifying operations, and sharpening core capabilities. As geopolitical change reshapes global trade flows, regionalisation is emerging as a cornerstone of strategy. Interestingly, CEOs view this shift to regionalisation and localisation not as a temporary adjustment, but as a long-term strategic move, with leaders reconfiguring supply chains and operations to stay closer to customers and reduce global exposure." Building for performance and resilience Irish CEOs are backing their confidence with action. Beyond those accelerating transformations (58% are planning to reshape their business this year), a further 40% plan to maintain current investment levels, signalling a sustained commitment to reshaping business portfolios. Funding strategies are measured; many are turning to debt or divesting non-core assets, while internal growth continues to be a key driver. Mergers, acquisitions and partnerships remain central to CEO strategy, with 98% ...

In this episode of Between Product and Partnerships, Cristina Flaschen sits down with Arvita Tripati, a seasoned healthcare product leader and advisor. They explore her unique journey from customer service in medical devices to leading product management in high-stakes, regulated environments.A Career Built on Curiosity and EmpathyArvita began career working with cosmetic and reconstructive lip implants. Over time, she explored quality, regulatory, privacy, and security roles, gradually noticing a common thread – a product mindset could improve compliance and user experience. By staying curious and saying “yes” to opportunities, she transitioned into formal product management, bringing an empathetic, human-centered perspective to highly regulated work.She emphasizes that empathy extends beyond patients. Every role, from HR to IT, has internal and external “customers.” Recognizing that and asking why decisions are made can open doors in unexpected ways.AI in HealthcareEarly projects relied on rules-based statistical models, like algorithms guiding radiofrequency ablation. Today, AI has become more adaptive, processing complex data in real time.She stresses that adoption is as much about trust and storytelling as it is about accuracy. Clinicians, patients, and regulators all need different levels of detail. For patients, a clear explanation of outcomes is key. Clinicians want actionable insights they can rely on. Regulators, like the FDA, demand evidence and reproducibility. Building confidence in AI requires tailoring communication to each audience and focusing on transparency.Navigating Regulation and Market RiskThe discussion highlights the tension between speed and compliance. Some companies launch products without FDA approval to move quickly, but this can backfire, creating reputational risk and undermining trust. Arvita argues that embedding validation, equity, and discovery into every stage of product development ensures both safety and long-term success.She recalls the FDA's collaborative approach during the COVID crisis, which allowed her team to bring products to market faster than usual while still meeting rigorous standards. Regulatory bodies, she notes, often want innovators to succeed, they just need assurance that claims are safe and evidence-based.Lessons from Clip Health During COVIDJoining Clip Health in May 2020, Arvita helped pivot from STI diagnostics to COVID testing. The team faced a critical choice, optimize for speed-to-result or clinician workflow. Speed won out, enabling rapid deployment, but revealed the importance of balancing urgency with discovery.This experience reinforced two key lessons, 1) speed does not equal success, and 2) embedding continuous discovery into product DNA is essential. Arvita notes that even under extreme pressure, pausing to understand workflow and user needs can determine whether a product thrives.Advice for Aspiring Product ManagersArvita offers guidance for those entering product roles, particularly in regulated or technical industries:Maintain a beginner's mindset and stay curious.Lead with empathy for both internal and external users.Consider equity, inclusivity, and the broader business impact of product decisions.Balance speed with thoughtful discovery. Sometimes slowing down enables you to go further, faster.Cristina adds that effective PMs know when to zoom out and reassess the problem at hand. Good product decisions are defensible, ethical, and grounded in real-world impact.For more insights on partnerships, integrations, and building SaaS ecosystems, visit www.pandium.com

CJ King, CTO at Torc Robotics, joins the show to talk about the future of autonomous trucking at scale. Instead of asking “can we build one self-driving truck?” Torc is asking, “how do we safely put 10,000 on the road?” From supply chain transformation to regulatory hurdles, CJ breaks down what it really takes to bring production-ready autonomous semis into the market and why the ripple effects will reach far beyond trucking.Key Takeaways• Scaling autonomous vehicles isn't about prototypes—it's about building production-ready systems from the ground up.• Trucks face unique technical challenges, from 1,000-meter perception needs to fully redundant systems that can't rely on cloud compute.• Removing driver limitations could extend operations from 8 hours a day to 20, unlocking major gains in supply chain efficiency.• Regulatory collaboration is critical—success depends on alignment with federal and state agencies, law enforcement, and logistics partners.• Adoption will come in step-functions: once proven safe and reliable, logistics companies are ready to adopt at scale.Timestamped Highlights00:45 – Torc's focus on hub-to-hub autonomous trucking02:03 – Why scaling to thousands of trucks matters more than building one prototype06:48 – The unique technical problems of trucks vs. passenger cars09:25 – How extended operating hours reshape logistics and supply chains14:17 – Working with regulators and law enforcement to ensure safety and compliance17:42 – AV3.0, synthetic data, and billions of miles of training for safer systems22:31 – Building public trust and societal acceptance of autonomous trucking25:21 – Why large-scale adoption will happen in step functions, not tricklesA Line That Stuck With Us“Our bare minimum is to drive as good as a human—our mission is to be safer than one.” – CJ KingCall to ActionIf you enjoyed this episode, share it with someone who cares about the future of tech and logistics. Make sure to follow the show so you never miss conversations that dig into how technology is reshaping our world.

In this episode of Medsider Radio, we sat down with Ahmed Elmouelhi, CEO of TRiCares.  TRiCares is developing Topaz, the first purpose-built transcatheter tricuspid valve replacement system — a technology designed specifically for the right side of the heart, where complex anatomy has made durable solutions elusive.Ahmed is a 20-year medtech veteran with leadership experience across electrophysiology, men's health, neuromodulation, and structural heart. Before joining TRiCares, he helped build multiple businesses at AtriCure and held key roles at Medtronic during the early days of TAVR. He also serves as Chairman of the American Heart Association in Minnesota.In this interview, Ahmed shares why adoption — not added complexity — is the ultimate measure of medtech innovation, how a small group of physician champions can accelerate clinical studies faster than internal resources alone, and why treating your board like collaborators in the “sandbox” leads to stronger partnerships and better outcomes.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ahmed Elmouelhi.

Thank you so much for listening to the Bob Harden Show, celebrating over 14 years broadcasting on the internet. On Tuesday's show, we visit with Florida State Senator Kathleen Passidomo about the assassination of Charlie Kirk and his celebration of life. We visit with Energy Policy Expert for Americans for Prosperity Faith Burns about the vulnerability of our energy grid and the need to speed up regulatory approvals. Boo Mortenson and I discuss some of the benefits but also the threats of Artificial Intelligence to human intelligence and development. We also visit Linda Harden about President Trump's announcement yesterday about developing science on autism and vaccine schedules. Please join us tomorrow when we visit with Cato Institute Chairman Emeritus Bob Levy and Professor Andrew Joppa. Access this or past shows at your convenience on my web site, social media platforms or podcast platforms.

In this episode, BioSpace's head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.

The Trump Administration's Regulatory Agenda is the starting point for David, Nita, and Burt's lively discussion of the consequences of the Administration's de-regulatory agenda and its efforts to exert presidential control over all executive agencies. The “nuclear option” for confirming nominees, judicial rulings questioning the constitutionality of administrative enforcement, and the impact of the budget debate make this a timely and informative conversation.Contact Fortney & Scott: Tweet us at @fortneyscott Follow us on LinkedIn Email us at info@fortneyscott.com Thank you for listening! https://www.fortneyscott.com/

Three whistleblowers brought a durable medical equipment (DME) provider to its knees.In two separate cases, the whistleblowers targeted Exactech, a manufacturer of total knee replacement (TKR) systems, resulting in a settlement of $8 million to resolve alleged violations of provisions of the False Claims Act (FCA).Famed whistleblower attorney Mary Inman, partner in the law firm of Whistleblower Partners, LLP, will report the excoriating details of the settlement during the next live edition of Monitor Mondays.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Cate Brantley at Zelis, will report on the news happening at the intersection of healthcare and congressional action.

Maja Vujinovic and Benjamin Tsai build a bullish case for cryptocurrencies in the months and years ahead. Maja says the current momentum will drive institutions to accelerate regulatory adoption in governments and companies. Ben says that a lot of institutional investors remain on the sidelines and will only bolster crypto markets once they buy in. Another case both panelists make for a bullish push: IPOs and crypto-centric companies being added to the SPX.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

“Europe Can Win in Applied AI — If We Play to Our Strengths”In one of the most focused and forward-looking sessions of the summit, Juliet Bailin of General Catalyst made a compelling case for why Europe is uniquely positioned to lead in applied AI—not by copying Silicon Valley, but by doubling down on what makes the continent distinct.Juliet opened with a reminder of Europe's superpowers:Regulatory complexity,Cultural and linguistic diversity, andStrong traditions in research and privacy.These aren't weaknesses—they're strategic advantages for human-centric, domain-specific, and trust-first AI.“Highly regulated industries are perfect for specialized AI,” Juliet argued. “And cultural diversity is crucial for building human-centric systems.”Rather than pursuing general-purpose models that require vast compute resources (a game already dominated by US giants), Juliet emphasized applied AI—targeted solutions built into real-world workflows. Europe's leadership in sectors like healthcare, finance, and mobility offers the perfect foundation.General Catalyst is backing this with:Incubation of applied AI startupsAI roll-ups of legacy businesses with strong distributionPublic-private convenings via the General Catalyst InstituteJuliet called on governments to do more than fund foundational research:“We need governments that can incentivize the adoption of European, homegrown applied AI companies.”That means clear pathways for public procurement, regulation that encourages innovation, and aligned industrial policy.Her message to entrepreneurs was crisp and actionable:Build in regulated industries where Europe leadsPrioritize trust-first AI—privacy, explainability, fairnessJoin the EU AI Champions Initiative → AIChampions.eu(A platform to connect startups with the corporates and investors driving Europe's AI future)Juliet closed with a powerful vision—not just of returns or GDP growth, but of rewriting the social and economic history of Europe:“If we do this right… future historians will talk about it at the next EUVC summit.”Why Europe? Because We're Built for ItApplied AI Is Europe's OpportunityA Call for Innovation-First PolicyWhat Founders Can DoFrom GDP to Legacy

In this episode, Tina Rathjen, from J.P. Morgan's Securities Services Regulatory Practice, is joined by Kara Kennedy, co-head of Kinexys at J.P. Morgan, to explore the rapidly evolving world of digital assets and blockchain technology. Together, they discuss the opportunities and challenges presented by distributed ledger technology (DLT) and decentralized finance (DeFi), recent regulatory changes, and J.P. Morgan's initiatives in the digital asset space. The conversation covers industry trends, regulatory sandboxes, digital identity, and how J.P. Morgan is preparing for the future of finance. Tune in for expert insights on how technology and regulation are shaping the digital asset ecosystem.    This episode was recorded on September 2, 2025.     This podcast is intended for institutional clients only. The views expressed in this podcast may not necessarily reflect the views of J.P. Morgan Chase & Co, and its affiliates, together J.P. Morgan, and do not constitute research or recommendation advice or an offer or a solicitation to buy or sell any security or financial instrument. Referenced products and services in this podcast may not be suitable for you, and may not be available in all jurisdictions. J.P. Morgan may make markets and trade as principal in securities and other asset classes and financial products that may have been discussed. For additional disclaimers and regulatory disclosures, please visit www.jpmorgan.com/disclosures.  © 2025 JPMorgan Chase & Company. All rights reserved. 

Europe's landmark crypto law, the Markets in Crypto-Assets, promised a unified market across 27 member states. But less than a year into rollout, national regulators are already pushing back on its central feature: passporting.Is MiCA bringing the clarity Europe's crypto industry needs or adding a new layer of uncertainty? In this episode of Byte-Sized Insight, we hear from the head of compliance and European regulatory affairs at CoinShares and the executive director of the European Crypto Initiative about passporting, regulatory arbitrage and whether MiCA can truly keep Europe competitive on the global stage.(00:39) MiCA and the single-market promise(01:31) Member State pushback on passporting across the EU(02:51) Regulatory competition and arbitrage risks(04:32) The challenge of 27 having national authorities(07:17) Compliance pressure on smaller firms(10:23) Clarity and consistency as the real test for MiCA's success(14:27) MiCA implementation still in progress(15:40) Europe's leadership moment in crypto regulation(16:00) MiCA's global ripple effects and the GENIUS ActThis episode was hosted and produced by Savannah Fortis, @savannah_fortis.This episode is brought to you by Coinlocally — launching the Academy Learn-to-Earn platform, where crypto education turns into real ownership. Earn CLYC tokens as you learn and use them for governance, staking, or trading perks. Plus, trade Convert, Spot, Futures, Grid Bots, Copy Trading, and MT5 in one secure app with some of the lowest fees in the industry. Cointelegraph podcast listeners get early access to the Academy and a $50 trading bonus at coinlocally.com.Follow Cointelegraph on X @Cointelegraph.Check out Cointelegraph at cointelegraph.com.If you like what you heard, rate us and leave a review!The views, thoughts and opinions expressed in this podcast are its participants alone and do not necessarily reflect or represent the views and opinions of Cointelegraph. This podcast (and any related content) is for entertainment purposes only and does not constitute financial advice, nor should it be taken as such. Everyone must do their own research and make their own decisions. The podcast's participants may or may not own any of the assets mentioned.

Host Jesse Hardin sits down with Stephanie Gunselman, head of Federal Government Relations at Equifax, for a wide-ranging look at how Washington is shaping the future of lending and credit reporting. From a cooling labor market and inflation to evolving priorities at the CFPB, they explore the latest legislative and regulatory developments — including open banking, data privacy, AI governance, medical debt rules, and more. Whether you're a lender, policy watcher, or data-driven strategist, this conversation will help you prepare for the policy shifts that could impact your business in 2025 and beyond.Economist Justin Begley of Moody's Analytics delivers our macroeconomic update.

In this episode of Medsider Radio, we sat down with Marc Penna, CEO of Voyager Biomedical. Voyager is a clinical-stage company tackling one of the most persistent challenges in dialysis care: reliable vascular access. Marc has more than 20 years of experience leading clinical research and regulatory programs across cardiology, vascular disease, and oncology. Since 2014, he has focused on early-stage ventures, with leadership roles at Intact Vascular and Vesper Medical — both acquired by Philips — as well as senior positions at Edwards Lifesciences, Boston Scientific, and AngioDynamics.In this interview, Marc shares how to pressure-test new medtech ideas, why collaboration with regulators and trial sites builds lasting credibility, and how disciplined fundraising and smart exit planning can set startups apart.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Marc Penna.

This episode of the Pipeliners Podcast welcomes back Keith Coyle, now serving as Chief Counsel at PHMSA, to discuss his new role and the agency's current priorities. The conversation highlights leadership changes within PHMSA, the administration's push for greater efficiency and impact, and the agency's updated approach to rulemaking, enforcement, and safety priorities. Listeners get a high-level view of how PHMSA is focusing its efforts to drive meaningful improvements in pipeline safety. Visit PipelinePodcastNetwork.com for a full episode transcript, as well as detailed show notes with relevant links and insider term definitions.

Join Tommy Shaughnessy as he sits down with Mike Dudas, Managing Partner at 6th Man Ventures, to discuss one of the most successful seed investments in crypto history. Mike shares the inside story of backing Pump.Fun years before it became a cultural phenomenon, generating over $800 million in fees and reaching a $5.5 billion FDV. From cold DMs to billion-dollar outcomes, this conversation explores venture capital strategy, founder evaluation, and navigating the intersection of AI and crypto investing.6th Man Ventures: https://6thman.ventures

Brandon Weichert highlights the immense power demands of AI and AGI data centers, requiring gigawatts of electricity and facing significant regulatory hurdles. He discusses the potential weaponization of AI, noting human nature's tendency to weaponize new technologies. Weichert shares personal experiences with AI tools like Grok, Gemini, and Claude, including instances of AI "diversion" rather than hallucination. He emphasizes the need to master this technology, as the substantial investment ensures its permanence. 1958

Newt talks with Patrick McLaughlin, a research fellow at the Hoover Institution, where he leads the QuantGov analytics project focusing on regulations. McLaughlin discusses the growth of regulatory requirements from 400,000 restrictive terms in 1970 to 1.1 million today, highlighting the economic friction and opportunity costs associated with regulatory accumulation. He estimates that if regulations had been held constant since 1980, the U.S. economy could be 25% larger by 2012, equating to a $4 trillion increase. They also discuss the impact of the Supreme Court's decision to end Chevron deference, which previously allowed agencies to interpret statutes with significant discretion. Their conversation concludes with an examination of Virginia Governor Glenn Youngkin's successful regulatory reforms, which include a 25% reduction in regulatory inventory and the use of AI for cost-benefit analysis, setting a new standard for regulatory management.See omnystudio.com/listener for privacy information.